Dr. Dillon Daniel Clarey, MD

Dr. Clarey practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Clarey's NPI, 1386133346, was assigned on May 5, 2018. Dr. Clarey graduated from University of Nebraska College of Medicine in 2018. Dr. Clarey holds Nebraska license 35818.

Dr. Clarey's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Clarey also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Clarey's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. Clarey is also affiliated with Columbus Community Hospital. The medical group on file is Columbus Community Hospital. Dmand AI also links Dr. Clarey to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Clarey practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Clarey's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Clarey is licensed in Nebraska.

CMS data shows 4,438 Medicare services from Dr. Clarey across 32 procedure codes in 2024, for 858 Medicare patients. Medicare paid $227,524 for them. Every service was in an office.

CMS counts 858 Medicare patients who saw Dr. Clarey in 2024. The largest group is 65 to 74, with 426 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Clarey's median patient age at 67, with 56% women.

In 2024, Dr. Clarey wrote 1,100 Medicare Part D claims for 422 patients. 97% of them were for generic drugs. CMS names the drug for 1,000 of them, across 19 drugs with 11 or more claims each, at $21,561 in total drug cost. In 2023, CMS named 199 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 66 out of 100 for Dr. Clarey for performance year 2024, reported as part of a group. Dr. Clarey accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 246 procedures of melanoma (skin cancer) excision by Dr. Clarey, more than 98% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Clarey, published from 2016 to 2022. 2020 was the busiest year, with 3. The most frequent topics are Blister, Diagnosis, Differential and Exanthema. Dr. Clarey has published most often in Am J Dermatopathol. Dr. Clarey's most frequent co-authors are Ryan Michael Trowbridge, MD, Corey J. Georgesen, MD and Taylor Kay Thieman.

CMS Open Payments shows 81 general payments to Dr. Clarey from 13 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 90% of the total. Janssen Pharmaceuticals, Inc paid the most, $409.

Dr. Clarey graduated from University of Nebraska College of Medicine in 2018.